Article
BeiGene-Novartis gastric cancer drug succeeds in late-stage trial
Rating:
0.0
Views:
99
Likes:
1
Library:
1
Drugmaker BeiGene Ltd said on Thursday the experimental drug it is developing with Swiss firm Novartis AG helped extend survival for patients with types of gastric cancer in a late-stage trial.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value